Geron (GERN) opened 2026 with Q1 revenue of US$51.8 million, a basic EPS loss of US$0.005, and net income loss of US$3.6 million. This set the tone for another earnings season where growth and profitability stay in focus. Over the last year the company has seen revenue move from US$76.9 million in Q4 2024 to US$196.1 million on a trailing twelve month basis, while the trailing basic EPS loss narrowed from US$0.27 to US$0.10. This leaves investors weighing ongoing losses against improving margins.

See our full analysis for Geron.

With the headline numbers on the table, the next step is to see how this earnings profile lines up with the prevailing growth and profitability narratives that follow.

Losses Narrow From US$28.9m To US$3.6m

• Net income loss moved from US$28.9 million in Q4 2025 to US$3.6 million in Q1 2026, while basic EPS loss went from US$0.04326 to US$0.00544 over the same periods.
• What stands out for the bullish narrative is how this smaller quarterly loss sits alongside trailing 12 month revenue of US$196.1 million and a trailing EPS loss of US$0.10, which bulls see as a base for much faster growth.
  • Bullish analysts are working with revenue growth forecasts of around 56.2% a year and earnings growth around 62.1% a year, which is far stronger than the 31.1% revenue growth modelled for the broader market benchmark.
  • Those optimistic views lean heavily on the idea that losses of US$67.3 million on a trailing basis can flip to profitability within about three years, so the recent step down from a US$83.5 million trailing loss in Q4 2025 is important for that story.

Bulls argue that if Geron keeps pairing strong revenue momentum with smaller quarterly losses, the long run earnings ramp they are pencilling in could look more achievable over time. 🐂 Geron Bull Case

Revenue Base Climbs To US$196.1m

• On a trailing 12 month view, total revenue has moved from US$76.9 million in Q4 2024 to US$196.1 million by Q1 2026, while the trailing net loss narrowed from US$174.6 million to US$67.3 million.
• Consensus narrative sees this bigger revenue base as the starting point for long term growth but also flags that the company is still loss making despite forecasts for 31.1% annual revenue growth and a path to profitability within three years.
  • Analysts collectively expect earnings to reach about US$174.7 million by around 2028 from a current trailing loss of US$67.3 million, which assumes margins shift from loss making to 27.9% over that period.
  • At the same time, the consensus price target of US$3.40 sits above the current US$1.58 share price, so the way this growing revenue line translates into actual profits is what separates that upside case from current reality.

Valuation Signals Versus Ongoing Losses

• The stock trades on a P/S of about 5.2x compared with an industry average of roughly 10.8x, and the current US$1.58 share price is well below the cited DCF fair value of US$20.08 while the business remains loss making on US$67.3 million of trailing losses.
• Bears focus on the fact that losses have grown at around 1% a year over the past five years and argue that even with a lower P/S multiple and a DCF fair value of US$20.08, the ongoing lack of profits and reliance on forecasts create real risk that the downside case plays out instead.
  • The bearish narrative points out that analysts in that camp see scope for revenue to reach about US$434.1 million by 2028 yet still treat US$1.00 as a justified target, which is below the current US$1.58 share price and well under the consensus target of US$3.40.
  • That gap between a low current P/S, a high modelled DCF fair value and a trailing loss of US$67.3 million is exactly what critics highlight when they question whether the projection of profits within three years will come through as expected.

Skeptics argue that until the company moves clearly away from its US$67.3 million trailing loss, the lower P/S multiple and large spread to DCF fair value can persist for some time. 🐻 Geron Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Geron on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

After weighing both the bullish and bearish narratives, the next step is to look directly at the numbers and timing that matters to you. If you want to see what has investors optimistic before making your own call, start with the 3 key rewards.

See What Else Is Out There

Geron is still working through US$67.3 million of trailing losses, and profitability remains out of reach despite a larger revenue base and ambitious forecasts.

If you want stocks where current results already look more dependable, check out the 74 resilient stocks with low risk scores today to focus on companies with steadier risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.